Ophthalmology

A Q&A with Alice T. Epitropoulos MD, FACS

Tear film stability, tear production, ocular surface health, and symptoms were all significantly improved with the use of punctal plugs.

Minimally invasive glaucoma surgery offers alternatives for patients looking for methods of treating glaucoma without affecting quality of life.

A higher composite dietary antioxidant index was found to decrease the chances of American adults developing cataracts.

Christine Funke, MD, explains minimally invasive glaucoma surgery and what types are available for patients.

Doctors can identify ways of proactively addressing glaucoma in patients by discussing options with their patients, says Christine Funke, MD.

Patients with neovascular age-related macular degeneration (nAMD) experienced improvements in central macular thickness and subretinal and intraretinal fluid after switching.

Christine Funke, MD, spoke about the role of doctors in making sure their patients are receiving proper care after being diagnosed with glaucoma.

New treatments for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) enhance patient care with gene therapies and new mechanisms of action on the horizon, explained Casey Koch, PharmD, from Select Health.

Christine Funke, MD, discusses how the treatment of glaucoma has evolved in her decade of experience.

The complete response letter (CRL) specifies that the current dosage duration of aflibercept is still safe but extending the duration is not approved.

Excessive use of digital devices and mental health issues can both contribute to the development of dry eye syndrome.

The topical ocular drug is an investigational new drug candidate that requires more well-controlled studies to establish efficacy, according to the FDA.

Both refractive and corneal astigmatism saw an increase in prevalence in children after the COVID-19 pandemic, with corneal changes potentially playing a part.

Michelle Hessen, OD, discusses how cyclosporine ophthalmic solution 0.09% is safe to use in patients with dry eye, as well as where future research should turn.

Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye.

The topical treatment had no significant effect on total or central corneal fluorescence staining score.

Clinical trials for diabetic macular edema (DME) continue to see disparities in enrollment.

The cause of age-related macular degeneration can be varied and symptoms are often not recognized immediately, according to Hasenin Al-khersan, MD.

Reducing the number of intravitreal injections to treat age-related macular degeneration (AMD) is a top priority in current treatment research, says Paul Hahn, MD, PhD.

Perfluorohexyloctane ophthalmic solution had high treatment satisfaction in those who took it for dry eye.

Knowing the risk factors of age-related macular degeneration (AMD) and consulting an ophthalmologist or optometrist can help to maintain vision, says Hasenin Al-khersan, MD.

Paul Hahn, MD, PhD, discussed signs and symptoms of age-related macular degeneration (AMD) during AMD Awareness Month.

Patients with varying stages of glaucoma saw no significant difference in outcomes between standard and enhanced monofocal intraocular lenses.

Signs and symptoms of age-related macular degeneration (AMD) are important to spot to prevent further deterioration of sight.

Wet age-related macular degeneration (AMD) can be managed using brolucizumab due to its efficacy.

The ranibizumab injection delivered through an implant device could be administered in a convenient schedule twice per year for the treatment of diabetic macular edema (DME).